Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.

Locharernkul C, Shotelersuk V, Hirankarn N.

J Clin Neurosci. 2011 Oct;18(10):1289-94. doi: 10.1016/j.jocn.2010.12.054. Epub 2011 Jul 28. Review.

PMID:
21802305
2.

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperavičiūtė D, Carrington M, Sills GJ, Marson T, Jia X, de Bakker PI, Chinthapalli K, Molokhia M, Johnson MR, O'Connor GD, Chaila E, Alhusaini S, Shianna KV, Radtke RA, Heinzen EL, Walley N, Pandolfo M, Pichler W, Park BK, Depondt C, Sisodiya SM, Goldstein DB, Deloukas P, Delanty N, Cavalleri GL, Pirmohamed M.

N Engl J Med. 2011 Mar 24;364(12):1134-43. doi: 10.1056/NEJMoa1013297.

3.

Association of serotonin transporter promoter (5-HTTLPR) and intron 2 (VNTR-2) polymorphisms with treatment response in temporal lobe epilepsy.

Hecimovic H, Stefulj J, Cicin-Sain L, Demarin V, Jernej B.

Epilepsy Res. 2010 Sep;91(1):35-8. doi: 10.1016/j.eplepsyres.2010.06.008. Epub 2010 Jul 23.

PMID:
20655708
4.

Multidrug resistance 1 (MDR1) gene polymorphisms in childhood drug-resistant epilepsy.

Alpman A, Ozkinay F, Tekgul H, Gokben S, Pehlivan S, Schalling M, Ozkinay C.

J Child Neurol. 2010 Dec;25(12):1485-90. doi: 10.1177/0883073810368997. Epub 2010 May 6.

PMID:
20448249
5.

Absence of a general association between ABCB1 genetic variants and response to antiepileptic drugs in epilepsy patients.

Grover S, Bala K, Sharma S, Gourie-Devi M, Baghel R, Kaur H, Gupta M, Talwar P, Kukreti R.

Biochimie. 2010 Sep;92(9):1207-12. doi: 10.1016/j.biochi.2010.04.008. Epub 2010 Apr 24.

PMID:
20417680
6.

Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.

Hung SI, Chung WH, Liu ZS, Chen CH, Hsih MS, Hui RC, Chu CY, Chen YT.

Pharmacogenomics. 2010 Mar;11(3):349-56. doi: 10.2217/pgs.09.162.

PMID:
20235791
7.

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.

Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J.

Epilepsia. 2010 Jun;51(6):1069-77. doi: 10.1111/j.1528-1167.2009.02397.x. Epub 2009 Nov 3. Erratum in: Epilepsia. 2010 Sep;51(9):1922.

8.

Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis.

Bournissen FG, Moretti ME, Juurlink DN, Koren G, Walker M, Finkelstein Y.

Epilepsia. 2009 Apr;50(4):898-903. doi: 10.1111/j.1528-1167.2008.01858.x. Epub 2008 Oct 24.

9.

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.

Kim DW, Lee SK, Chu K, Jang IJ, Yu KS, Cho JY, Kim SJ.

Epilepsy Res. 2009 Mar;84(1):86-90. doi: 10.1016/j.eplepsyres.2008.12.001. Epub 2009 Jan 22.

PMID:
19167193
10.

Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression.

Kwan P, Poon WS, Ng HK, Kang DE, Wong V, Ng PW, Lui CH, Sin NC, Wong KS, Baum L.

Pharmacogenet Genomics. 2008 Nov;18(11):989-98. doi: 10.1097/FPC.0b013e3283117d67.

PMID:
18784617
11.

Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population.

Locharernkul C, Loplumlert J, Limotai C, Korkij W, Desudchit T, Tongkobpetch S, Kangwanshiratada O, Hirankarn N, Suphapeetiporn K, Shotelersuk V.

Epilepsia. 2008 Dec;49(12):2087-91. doi: 10.1111/j.1528-1167.2008.01719.x. Epub 2008 Jul 14. Erratum in: Epilepsia. 2009 Apr;50(4):971.

12.

The clinical impact of pharmacogenetics on the treatment of epilepsy.

Löscher W, Klotz U, Zimprich F, Schmidt D.

Epilepsia. 2009 Jan;50(1):1-23. doi: 10.1111/j.1528-1167.2008.01716.x. Epub 2008 Jul 8. Review.

13.

A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy.

Zimprich F, Stogmann E, Bonelli S, Baumgartner C, Mueller JC, Meitinger T, Zimprich A, Strom TM.

Epilepsia. 2008 Jun;49(6):1108-9. doi: 10.1111/j.1528-1167.2008.01549_4.x. No abstract available.

14.

Association of polymorphisms in NR1I2 and ABCB1 genes with epilepsy treatment responses.

Hung CC, Jen Tai J, Kao PJ, Lin MS, Liou HH.

Pharmacogenomics. 2007 Sep;8(9):1151-8.

PMID:
17924830
15.

Association of MDR1 (C3435T) polymorphism and resistance to carbamazepine in epileptic patients from Turkey.

Ozgon GO, Bebek N, Gul G, Cine N.

Eur Neurol. 2008;59(1-2):67-70. Epub 2007 Oct 4.

PMID:
17917461
16.
17.

Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese.

Kwan P, Baum L, Wong V, Ng PW, Lui CH, Sin NC, Hui AC, Yu E, Wong LK.

Epilepsy Behav. 2007 Aug;11(1):112-7. Epub 2007 May 22.

PMID:
17521963
18.

Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A.

Heinzen EL, Yoon W, Tate SK, Sen A, Wood NW, Sisodiya SM, Goldstein DB.

Am J Hum Genet. 2007 May;80(5):876-83. Epub 2007 Apr 3.

19.

Supplemental Content

Support Center